IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Shareholders’ equity 2013–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) shareholders’ equity at each fiscal year-end, per SEC filings.
$698.6MFY2025 · since FY2013: $17.6M → $698.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $698.6M | -1.7% |
| FY2024 | $710.4M | +21.5% |
| FY2023 | $584.6M | — |
| FY2018 | $466.2M | +220.4% |
| FY2017 | $145.5M | -12.8% |
| FY2016 | $166.9M | +60.5% |
| FY2015 | $104.0M | +132.0% |
| FY2014 | $44.8M | +154.8% |
| FY2013 | $17.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice